test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ATRCAtricure Inc
Recent Activity
New Position
0.45%
$1.514M
54,000 shares@ $28.04 avg price
CTMXCytomx Therapeutics Inc
Recent Activity
New Position
0.32%
$1.08M
915,000 shares@ $1.18 avg price
NVNOEnvveno Medical Corporation
Recent Activity
New Position
0.24%
$802,771
238,920 shares@ $3.36 avg price
TPSTTempest Therapeutics Inc
Recent Activity
New Position
0.23%
$763,000
545,000 shares@ $1.4 avg price
PMNPromis Neurosciences Inc
Recent Activity
New Position
0.22%
$726,744
581,395 shares@ $1.26 avg price
UNCYUnicycive Therapeutics Inc
Recent Activity
New Position
0.18%
$600,837
1.473M shares@ $0.41 avg price
APLTApplied Therapeutics Inc
Recent Activity
New Position
0.15%
$476,850↓ Put
56,100 shares@ $8.5 avg price
CLRBCellectar Biosciences Inc
Recent Activity
New Position
0.14%
$460,100
215,000 shares@ $2.14 avg price
BTTRBetter Choice Co Inc
Recent Activity
New Position
0.09%
$278,215
133,117 shares@ $2.1 avg price
XPONExpion360 Inc
Recent Activity
New Position
0.04%
$106,372
2.057M shares@ $0.06 avg price